论文部分内容阅读
目的探讨原发性肝癌破裂出血急诊介入的临床疗效。方法回顾性分析采用介入栓塞技术对我院16例原发性肝癌破裂出血的治疗情况。结果本组病例均行TAE获得有效止血。其中2例获得Ⅱ期手术治疗,1例因术前失血过多而死于肝功能衰竭,13例多次介入肿瘤缩小。一年存活率为37.5%(6/16)。结论介入栓塞治疗急诊肝癌破裂出血创伤小,适应证广,临床疗效确切,可作为急诊肝癌破裂出血的首选治疗方法。
Objective To investigate the clinical efficacy of emergency interventional treatment of ruptured liver cancer. Methods The clinical data of 16 cases of primary hepatocellular carcinoma (HCC) hemorrhage treated by interventional embolization were retrospectively analyzed. Results This group of patients underwent TAE effective hemostasis. Two of them were treated with stage II surgery, one died of liver failure due to preoperative hemorrhage and thirteen patients had multiple tumor interventions. One-year survival rate was 37.5% (6/16). Conclusion Interventional embolization in the treatment of acute hepatocellular carcinoma rupture bleeding trauma, indications wide, clinical curative effect, can be used as the first choice for the treatment of hemorrhagic liver cancer rupture.